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Objective: Notch receptors determine cell fate by regulating transcription, an event mediated by the
Notch intracellular domain (NICD), which is generated by proteolysis brought about by Notcheligand
interactions. Since Notch activation or exposure to interleukin (Il)6 have similar effects in chondrocytes,
we explored whether interleukin 6 (Il6) contributes to the mechanisms of Notch action in these cells.
Method: NICD was overexpressed in primary chondrocytes from RosaNotch mice, where the Rosa26 pro-
moter precedes a loxP-ﬂanked STOP cassette followed by the NICD coding sequence. Cells were infected
with adenoviral vectors expressing Cre to induce NICD or green ﬂuorescent protein (GFP) as control.
Gene expression was determined by quantitative reverse transcription-polymerase chain reaction (qRT-
PCR). Il6 protein concentration in the culture media was determined by enzyme-linked immunosorbent
assay (ELISA). To test the mechanisms of Notch action on Il6 expression, cells were transfected with a
fragment of the Il6 promoter or control vector pGL3, or transcriptionally arrested with 5,6-dichloro-1-b-
D-ribofuranosylbenzimidazole. Il6 was inhibited with a neutralizing antibody, whereas a normal
immunoglobulin G (IgG) was used as control.
Results: NICD induced Il6 mRNA and protein, and transactivated the Il6 promoter without affecting Il6
mRNA stability. Il6 neutralization had no impact on gene expression under basal conditions, and did not
modify the effects of NICD on sex determining region-Y-related high mobility group-box gene (Sox)9,
collagen type II a1 (Col2a1) and collagen type X a1 (Col10a1) expression. Conversely, Il6 neutralization
opposed aggrecan (Acan) suppression and prevented matrix metalloprotease (Mmp)13 induction by
NICD.
Conclusion: Il6 mediates suppression of Acan and induction of Mmp13 expression by Notch in
chondrocytes.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The Notch1 to Notch4 receptors, and the jagged (Jag)1 and 2,
and delta-like (Dll)1, 3 and 4 ligands are transmembrane proteins
that relay signals between adjacent cells, thereby determining cell
fate and function1. Interactions of Notch with Jag or Dll result in
sequential proteolytic cleavages by extracellular metalloproteases
and by the g-secretase protein complex, leading to the release of
the intracellular domain of Notch (NICD) to the cytoplasm2. NICD
translocates to the nucleus and associates with the DNA binding
protein EpsteineBarr virus latency C-promoter binding factor 1,
suppressor of hairless, and lag1 (CSL), also known as Rbpjk in mice,: S. Zanotti, Department of
4 Woodland Street, Hartford,
-8053.
tti).
s Research Society International. Pand with mastermind-like proteins. Subsequently, the transcrip-
tional repressors associated with Rbpjk are displaced by tran-
scriptional activators, resulting in the induction of Notch target
genes, such as those encoding for hairy enhancer of split (Hes) and
Hes related with YRPW-motif (Hey)3,4.
Chondrocytes are cartilage forming cells of mesenchymal origin,
and proliferation and differentiation of growth plate chondrocytes
results in linear growth of long bones5. Chondrocytes in articular
cartilage derive from mesenchymal precursors found at the artic-
ular surface, and under physiological conditions, these cells express
proteoglycan (Prg)4, sex determining region-Y-related high
mobility group-box gene (Sox)9, aggrecan (Acan) and collagen type
II a1 (Col2a1) and preserve the function of the extracellular ma-
trix6,7. Changes in the synovial ﬂuid concentration of Prg4, and
suppressed Sox9, Acan and Col2a1 transcript levels associated to
increased expression of collagen type X a1 (Col10a1) by articular
chondrocytes, are observed when cartilage integrity is compro-
mised8e11. These events are coupled to the induction of geneublished by Elsevier Ltd. All rights reserved.
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metallopeptidase with thrombospondin type 1 motif (Adamts)4
and matrix metalloprotease (Mmp)13, and to the expression of
mediators of inﬂammation, such as interleukin (Il)612e14.
Although Notch signaling suppresses chondrogenesis and dif-
ferentiation of hypertrophic chondrocytes, under selected condi-
tions, overexpression of NICD in chondrocytes induces Col10a1 and
Mmp13 transcripts15e22. Increased expression of components of the
Notch signaling pathway and nuclear localization of the intracel-
lular domains of NOTCH1 and NOTCH2 are observed in human
osteoarthritic chondrocytes, indicating that activation of Notch
signaling is associated with cartilage degeneration23e25. Accord-
ingly, inactivation of Rbpjk in chondrocytes or suppression of Notch
by a g-secretase inhibitor prevents surgically induced cartilage
degeneration, suggesting that activation of Notch signaling is
detrimental to the integrity of articular cartilage25. However, the
mechanisms that mediate the effects of Notch on chondrocyte
function are understood partially.
Notch induces interleukin 6 (Il6) expression in cells of mesen-
chymal origin, and exposure of bovine, rabbit, and human chon-
drocytes to Il6 phenocopies selected effects of Notch in murine
chondrocytes26e29. In this study, we investigated whether Notch
regulates Il6 expression in chondrocytes and whether Il6 mediates
the effects of Notch in these cells. To this end, primary chondrocyte-
enriched cells were harvested from RosaNotch mice where Cre
recombination induces the expression of NICD following excision of
a loxP-ﬂanked STOP cassette, placed between the Rosa26 promoter
and the NICD coding sequence30.
Methods
Primary chondrocyte-enriched cell cultures
RosaNotch mice, generated by D.A. Melton (Harvard University,
Cambridge, MA), were obtained from Jackson Laboratories (Bar
Harbor, ME)30. Chondrocyte-enriched cells were obtained from 3 to
4 day oldmale and female littermate RosaNotch or wild-type C57BL/6
mice and cultured independently in order to retain the individual
identity of the donor. The distal epiphysis of the femur, tibia, hu-
merus, ulna and radius, and the proximal epiphysis of the tibia and
ulna were dissected under a Unitron Z850 stereo microscope
(Unitron, Commack, NY), and trabecular bone removed to limit
contamination from osteoblastic cells. Cartilage was transferred to
high glucose Dulbecco’s modiﬁed Eagle’s medium (DMEM, Life
Technologies, Grand Island, New York) and digested with 0.25%
trypsin in 0.9 mM EDTA (Life Technologies) for 40 min at 37C with
continuous mixing. Subsequently, cartilage was exposed to DMEM
containing 10% fetal bovine serum (FBS, Atlanta Biologicals, Nor-
cross, GA) and 200 U/ml of type II collagenase from Clostridium
histolyticum (Worthington Biochemical Corporation, Lakewood, NJ)
for 2e4 h at 37C with continuous mixing. Following digestion,
tissue debris was removed by straining through a 70 mmmembrane
and chondrocyte-enriched cells were collected by centrifugation at
500 g for 5 min. Cells were seeded at a density of 50,000 cells/cm2
and cultured in DMEM supplemented with 10% FBS at 37C in a
humidiﬁed 5% CO2 incubator21,31. Experimental protocols were
approved by the Animal Care and Use Committee of Saint Francis
Hospital and Medical Center.
Adenoviral infection
Primary chondrocyte-enriched cells from RosaNotch mice were
transferred to DMEM containing 2% FBS for 1 h and exposed
overnight to 100 multiplicity of infection of replication defective
recombinant adenoviruses (Ads). An adenoviral vector expressingCre recombinase under the control of the cytomegalovirus (CMV)
promoter (AdeCMVeCre, Vector Biolabs, Philadelphia, PA) was
used to excise the STOP cassette and allow NICD expression. An
adenoviral vector where the CMV promoter directs expression of
green ﬂuorescent protein (GFP; AdeCMVeGFP, Vector Biolabs) was
used as control. Following infection, primary chondrocyte-enriched
cells were allowed to recover for 24e48 h and cultured in the
presence of DMEM containing 10% FBS21. At conﬂuence, cultures
were exposed to 100 mg/ml ascorbic acid (SigmaeAldrich, Saint
Louis, MO) to prevent loss of chondrocyte phenotype and promote
acquisition of a mature chondrocyte phenotype32. Activation of
Notch signaling in RosaNotch cells expressing Cre recombinase and
the effects of Notch on the chondrocyte phenotype were conﬁrmed
in independent cultures frommale or femalemice and the effects of
Notch were not sexually dimorphic (data not shown)21,33e36.
Therefore, observations from cell cultures obtained from mice of
either sex were pooled for analysis of results.
Cytochemical staining, enzyme-linked immunosorbent assay (ELISA)
and Il6 neutralization
To determine the formation of chondrogenic and mineralized
nodules, cultures from RosaNotchmice were ﬁxed for 10 min at room
temperature in 3.7% formaldehyde in phosphate buffered saline
and subsequently stained with 1% alcian blue in 3% acetic acid, or
2% alizarin red in H2O (all from SigmaeAldrich). Images were ac-
quired with a Coolpix 995 digital camera mounted on an Eclipse
TS100 inverted microscope equipped with contrast phase lenses
(all from Nikon Inc., Melville, NY).
To explore whether NICD induces Il6 protein levels, conﬂuent
RosaNotch chondrocyte-enriched cells were cultured for 3 days
before exposure for 24 h to DMEM containing 100 mg/ml ascorbic
acid. Il6 concentration in the mediumwas measured with a mouse
Il6 ELISA kit, in accordance to the manufacturer’s instructions (BD
Biosciences, San Jose, California).
In selected experiments, RosaNotch chondrocyte-enriched cells
were exposed to DMEM for 6 h and subsequently exposed DMEM
containing 1 mg/ml neutralizing murine monoclonal immuno-
globulin G (IgG) against Il6 (clone B-E8; EMD Millipore, Billerica,
MA) or control murine normal IgG (Santa Cruz Biotechnology, Santa
Cruz, CA).
Transient transfections
To assess whether NICD regulates Il6 transcription in chon-
drocytes, chondrocyte-enriched cells from RosaNotch mice were
transiently transfected with a 1.3 kilobase (kb) fragment of the
murine Il6 promoter cloned into pGL3 basic, upstream of the
luciferase (Luc) coding sequence (Il6eLuc; D.L. Allen, University of
Colorado Boulder, Boulder, CO)37. To induce Notch signaling inwild-
type chondrocyte-enriched cells, a 2.4 kb DNA fragment containing
the murine NICD coding sequence (J.S. Nye, Columbia University,
New York City, NY) was cloned in the pcDNA3.1 expression vector
(Life Technologies, Carlsbad, CA) downstream of the CMV promoter
to generate pcDNAeNICD38. To determine the effects of NICD on
Notch transactivation in wild-type chondrocytes, cells were tran-
siently transfected with pcDNAeNICD or with pcDNA3.1, as control,
and co-transfected with a construct where six multimerized
dimeric CSL binding sites linked to the b-globin basal promoter
govern luciferase expression (12  CSLeLuc; L.J. Strobl, Munich,
Germany)39. To conﬁrm the effects of NICD on the transactivation of
the Il6 promoter, wild-type chondrocytes transiently transfected
with pcDNAeNICD or with pcDNA3.1 were co-transfectedwith Il6e
Luc. To correct for transfection efﬁciency, cells were co-transfected
with a construct where the CMV promoter directs b-galactosidase
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were exposed to a 3 ml/2 mg mix of FuGene6 (Roche, Indianapolis,
IN) and DNA for 16 h before adenoviral infection with AdeCMVe
Cre or AdeCMVeGFP. Wild-type chondrocyte cultures at 70%
conﬂuence were exposed to a 3 ml/2 mg mix of X-tremeGENE 9
(Roche) and DNA for 16 h. Cells were harvested after 48 h in
luciferase extraction buffer (Roche), and luciferase and b-galacto-
sidase activities were measured on an Optocomp luminometer
(MGM Instruments, Hamden, CT), according to manufacturer’s in-
structions (Roche).
Quantitative reverse transcription-polymerase chain reaction (qRT-
PCR)
Total RNA from chondrocyte-enriched cells from RosaNotch mice
was extracted with the RNeasy mini kit, according to manufac-
turer’s instructions (Qiagen, Valencia, CA) and changes in gene
expression determined by qRT-PCR. Half to one microgram of total
RNA were reverse-transcribed using the iScript cDNA synthesis kit
(BioRad, Hercules, CA), according to manufacturer’s instructions,
and ampliﬁed in the presence of speciﬁc primers (Table I; all from
Integrated DNA Technologies (IDT)), and iQ SYBR Green Supermix
(BioRad) at 60C for 35 cycles. mRNA copy number was estimated
by comparison to a 10-fold serial dilution of cDNA for Acan,
Adamts4, Col10a1, Il6, Mmp13 and Sox9 (all from Thermo Scientiﬁc,
Rockford, IL), Col2a1, Hes1, ribosomal protein l (Rpl)38 (all from
American Type Culture Collection, Manassas, VA), Prg4 (Source
BioScience, Nottingham, United Kingdom), Hey1 and Hey2 (both
from T. Iso, University of Southern California, Los Angeles, CA) and
Hey-like (HeyL; from D. Srivastava, University of Texas South-
western Medical Center, Dallas, TX)4,40e42. Reactions wereTable I
Primers used for qRT-PCR. Forward (Fwd) and reverse (Rev) primers used to
determine changes in gene expression by qRT-PCR. GenBank accession numbers for
the transcript variants recognized by primer pairs are indicated.
Gene Strand Primer sequence GenBank
accession
number
Acan Fwd 50-ATGGTCCTTCTATGACATACACTCC
CCG-30
NM_007424
Rev 50-TTGTTACAGCGCCACCAAGG-30
Adamts4 Fwd 50-GATGTGTGCAAGCTTACCT-30 NM_172845
Rev 50-CATCCGTAACCTTTGGAGA-30
Col2a1 Fwd 50-GACCCAAACACTTTCCAACCGCAGT-30 NM_031163;
NM_003396Rev 50-TCATCAGGTCAGGTCAGCCATT-30
Col10a1 Fwd 50-CAGGCTTTCTGGGATGCCGCTTGT-30 NM_009925
Rev 50-GGGCACCTACTGCTGGGTAA-30
Hes1 Fwd 50-ACCAAAGACGGCCTCTGAGCACAGAA
AGT-30
NM_008235
Rev 50-ATTCTTGCCCTTCGCCTCTT-30
Hey1 Fwd 50-ATCTCAACAACTACGCATCCCAGC-30 NM_010423
Rev 50-GTGTGGGTGATGTCCGAAGG-30
Hey2 Fwd 50-AGCGAGAACAATTACCCTGGGCAC-30 NM_013904
Rev 50-GAGGTAGTTGTCGGTGAATTGG-30
HeyL Fwd 50-CAGTAGCCTTTCTGAATTGCGAC-30 NM_013905
Rev 50-GCTTGGAGGAGCCCTGTTTCT-30
Il6 Fwd 50-CGGCCTTCCCTACTTCACAAGTCCG-30 NM_031168
Rev 50-CAGGTCTGTTGGGAGTGGTATCC-30
Mmp13 Fwd 50-GGAAGACCTTGTGTTTGCAGAGC-30 NM_008607
Rev 50-CACTGTAGACTTCTTCAGGATTCCCG-30
Prg4 Fwd 50-CGCCTTTTCCAAAGATCAATACTA-30 NM_021400;
NM_001110146Rev 50-GTGGTAATTGCTCTTGCTGTT-30
Rpl38 Fwd 50-AGAACAAGGATAATGTGAAGTTCAAG
GTTC-30
NM_001048057;
NM_001048058;
NM_023372Rev 50-CTGCTTCAGCTTCTCTGCCTTT-30
Sox9 Fwd 50-CCTACTACAGTCACGCAGCCG-30 NM_011448
Rev 50-GGGTTCATGTAAGTGAAGGTGGA-30conducted in a CFX96 real time PCR detection system (BioRad),
ﬂuorescence monitored during every PCR cycle at the annealing
step and speciﬁcity of the reaction assessed by analysis of melting
curves.
RNA decay experiments
To establish the effects of NICD on the stability of Il6mRNA, RNA
polymerase 2 was inhibited in conﬂuent chondrocyte-enriched cell
cultures from RosaNotchmice by exposure to 300 mM5,6-dichloro-1-
b-D-ribofuranosylbenzimidazole (DRB, BioMol, Plymouth Meeting,
PA). Il6mRNA levels at various times following the exposure to DRB
were determined in total RNA extracts by qRT-PCR analysis. The
slopes of mRNA decay were established by ﬁtting the log 10 of the
percentage of Il6 transcript levels corrected for Rpl38 expression
over corrected Il6 transcripts before exposure to DRB against time
by linear regression.
Statistical analysis
Estimates and associated uncertainty are expressed as means
and 95% conﬁdence interval, respectively. Each observation repre-
sents an independent culture from individual mice and is the
average of two technical replicates. Normality of data distribution
was determined with 95% conﬁdence by the ShapiroeWilk test.
Signiﬁcance of statistical differences was tested for pairwise com-
parisons by the Student’s t-test with a P < 0.05 and for multiple
comparisons by applying the Bonferroni correction with a
P < 0.025043. Statistical differences between slopes of regression
lines of corrected Il6 mRNA levels against time were determined by
analysis of covariance44. Statistical analyses were performed using
Microsoft Ofﬁce Excel 2003 SP2 (Microsoft, Redmond, WA) or
PASW software version 18.0.0 (IBM, Armonk, NY).
Results
NICD induces Il6 by a transcriptional mechanism in chondrocyte-
enriched cells
Exposure to Il6 recapitulates selected effects of Notch in chon-
drocytes, and we tested whether Notch signaling regulates Il6
expression in chondrocyte-enriched cells from RosaNotch mice
infected with AdeCMVeCre to induce NICD or with control Ade
CMVeGFP26e29. Analysis of mRNA levels by qRT-PCR revealed that
activation of Notch signaling induced a seven fold increase in Il6
expression [Fig. 1(A)]. To establish whether induction of Il6 tran-
scripts by Notch translates into increased Il6 production, levels of
Il6 protein were measured by ELISA in the supernatant of RosaNotch
chondrocytes. Il6 concentration in the culture medium of controls
and of cells overexpressing NICD was about 20 pg/ml and 290 pg/
ml, respectively [Fig. 1(B)], demonstrating that Notch caused a 15-
fold increase of Il6 protein levels and conﬁrming that activation of
Notch signaling in chondrocytes induces Il6.
To study themechanisms that mediate induction of Il6 by Notch,
the effects of Notch activation on the transactivation of a transiently
transfected 1.3 kb fragment of the Il6 promoter (Il6eLuc) or on
control pGL3 vector were tested in chondrocyte-enriched cells from
RosaNotch littermate mice. Activity of pGL3 was not induced by
Notch in comparison to controls, indicating that pGL3 does not
contain regulatory DNA elements responsive to Notch signaling in
chondrocytes. In control cells, activity of Il6eLuc was about 100-
fold greater than the activity of pGL3, suggesting that under con-
trol conditions the Il6 promoter is transactivated in chondrocytes
[Fig. 1(C)]. In accordancewith the stimulatory effects of Notch on Il6
mRNA levels, Il6eLuc was transactivated in the context of Notch
Fig. 1. NICD induces Il6 expression by transcriptional mechanisms. Primary RosaNotch chondrocyte-enriched cells were infected with AdeCMVeCre (CRE, full circles) to induce NICD
or with control AdeCMVeGFP (GFP, empty circles). In panel A, total RNA was extracted 3 days after adenoviral infection, and changes in gene expression analyzed by qRT-PCR. Data
are expressed as ratio of Il6 copy number over Rpl38 copy number. Observations represent cultures from individual mice, n ¼ 8. * indicates differences between CRE and GFP. In
panel B, Il6 concentration in the culture medium was determined by ELISA. Observations represent cultures from individual mice, n ¼ 3. * indicates a difference between CRE and
GFP. In panel C, cells were transfected with the pGL3 luciferase expression vector or with a fragment of the Il6 promoter cloned in pGL3 (Il6eLuc), and a b-galactosidase expression
vector 24 h before adenoviral infection and harvested after 48 h. Data are expressed as luciferase activity corrected for b-galactosidase activity, relative to corrected luciferase
activity in control cells transfected with pGL3. Observations represent cultures from individual mice n ¼ 4. * indicates differences between CRE and GFP. # indicates a difference
between Il6eLuc and pGL3 activity in cells expressing GFP. þ indicates a difference between Il6eLuc and pGL3 activity in cells expressing CRE. In panel D, chondrocytes were
transcriptionally arrested with DRB (time 0), and total RNA harvested at the indicated times was ampliﬁed by qRT-PCR. Data are percentage of Il6 mRNA copy number corrected for
Rpl38 copy number, relative to corrected expression of Il6 at the time of exposure to DRB, plotted vs time (h). Intercept and slope of regression lines were calculated by linear
regression of corrected Il6 expression over time.
Fig. 2. Transient overexpression of NICD transactivates the Il6 promoter. Primary
chondrocyte-enriched cells from littermate wild-type C57BL/6 mice were transfected
with pcDNAeNICD (NICD, full circles) to induce NICD or with control pcDNA3.1
(pcDNA, empty circles). Cells were co-transfected with the pGL3 luciferase expression
vector, the 12-CSLeLuc reporter (12  CSL) or a fragment of the Il6 promoter cloned in
pGL3 (Il6eLuc), and a b-galactosidase expression vector. Chondrocytes were harvested
after 48 h. Data are expressed as luciferase activity corrected for b-galactosidase ac-
tivity, relative to corrected luciferase activity in control cells transfected with pGL3.
Observations represent cultures from individual mice n ¼ 6. * indicates differences
between NICD and pcDNA. # indicates a difference between 12  CSL, or Il6eLuc, and
pGL3 activity in cells transfected with pcDNA. þ indicates a difference between
12  CSL, or Il6eLuc, and pGL3 activity in cells transfected with NICD.
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induction of Il6 mRNA and protein levels by Notch, indicating that
additional regulatory regions present in the intact Il6 locus deter-
mine the magnitude of Il6 induction by Notch. To assess whether
Notch regulates the stability of Il6 transcripts, Il6 expression was
determined by qRT-PCR in RosaNotch chondrocyte-enriched cells
exposed to DRB, an inhibitor of mRNA transcription. The estimated
half-life of the Il6 transcript was 1.2 h, and Notch did not affect
the rate of Il6 mRNA decay [Fig. 1(D)], indicating that post-
transcriptional mechanisms do not mediate the effects of Notch
on Il6 expression.
To induce Notch activity in chondrocytes by alternate mecha-
nisms, chondrocyte-enriched cells from wild-type C57BL/6 mice
were transiently transfected with pcDNAeNICD or with control
pcDNA3.1. To determine whether pcDNAeNICD activates the Notch
signaling pathway, cells were co-transfected with pGL3 or with the
12  CSLeLuc reporter. Transient NICD overexpression had no
impact on pGL3 activity whereas it induced 12  CSLeLuc trans-
activation, conﬁrming activation of Notch signaling (Fig. 2). Under
basal conditions, Il6eLuc activity was about eight fold higher than
pGL3 activity, whereas in the context of Notch induction Il6eLuc
transactivation was about four fold higher than in the presence of
pcDNA. These results suggest that the Il6 promoter has basal ac-
tivity in chondrocytes and conﬁrm that Notch induces Il6 expres-
sion by transcriptional mechanisms.
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expression
Exposure of chondrocytes to Il6 phenocopies selected effects
of Notch signaling, and we asked whether Il6 mediates the effects
of Notch on the expression of chondrocyte gene markers27e29.
To investigate this possibility, chondrocyte-enriched cells from
RosaNotch mice were exposed to a neutralizing murine monoclonal
IgG raised against Il6 or murine IgG, either in the context of Notch
activation or under basal conditions.
Notch induced Hey1, Hey2 and HeyL, and to a lesser extent, Hes1
transcripts, either in cells exposed to the neutralizing Il6 antibody
or to normal IgG (Fig. 3), demonstrating that inhibition of Il6 does
not alter Notch transactivation in chondrocyte-enriched cells. In
agreement with previous results, Notch activation suppressed Sox9
and Col2a1 mRNA levels and induced Col10a1 expression in cells
exposed to normal IgG20,21,45. Similar results were obtained in the
presence of the Il6 neutralizing antibody, indicating that Il6 is not
required for these effects of Notch in chondrocytes. Levels of Il6
mRNA were not affected by the neutralizing Il6 antibody, either
under basal conditions or in the context of NICD overexpression,
excluding the possibility that the neutralizing Il6 antibody pre-
cludes induction of Il6 expression by Notch (Fig. 4). Inhibition of Il6
in the absence of Notch had no impact on Sox9, Col2a1 and Col10a1
expression, suggesting that basal Il6 levels are not required for
expression of these chondrocyte gene markers.
Although Notch activation had no effect on Prg4 transcripts,
Notch suppressed Acan mRNA levels and this effect was opposed
partially by Il6 neutralization, indicating that Notch inhibits
expression of selected gene markers of chondrocyte function and
this effect is mediated in part by Il6. Notch activation did not affect
Adamts4 expression, whereas it increasedMmp13 transcripts levels,
conﬁrming that under selected conditions NICD overexpressionFig. 3. Il6 neutralization does not oppose induction of Notch target genes by NICD. Primary R
to induce NICD or with control AdeCMVeGFP (GFP, empty circles). Cells were cultured for
before exposure to murine Il6 antibody (Anti-Il6) or control normal murine IgG. Total RNAw
by qRT-PCR. Data are expressed as ratio of Hey1, Hey2, HeyL and Hes1 copy number over
* indicates differences between CRE and GFP in the presence of IgG. ** indicates differenceinduces gene markers of cartilage matrix degradation (Fig. 5)20,21.
Neutralization of Il6 opposed the stimulatory effects of Notch on
Mmp13 expression, indicating that Il6 is required for this effect of
Notch in chondrocytes (Fig. 5). Il6 neutralization in cells expressing
GFP did not affect Prg4, Acan, Adamts4 andMmp13 transcript levels,
conﬁrming that Il6 is dispensable for expression of selected chon-
drocyte gene markers.
Discussion
In this study, we explored the mechanisms that mediate the
regulation of gene expression by the Notch signaling pathway in
chondrocytes. Several studies have established Notch as a sup-
pressor of chondrogenesis in vivo, and this effect is consistent with
the role of Notch as an inhibitor of mesenchymal cell differentia-
tion1. However, the role of Notch signaling in differentiated cells of
the chondrocyte lineage is controversial, since both suppression of
hypertrophic differentiation and elongation of the hypertrophic
zone of the growth plate have been described as effects of NICD
overexpression under the control of the Col2a1 promoter18,20,22.
The validity of the RosaNotch system to study the effects of Notch
signaling in primary chondrocyte-enriched cell cultures was
conﬁrmed by the induction of Notch target genes following infec-
tion with AdeCMVeCre (data not shown). In agreement with
previous ﬁndings, Notch induced expression of Hey1, 2 and L to a
greater extent than Hes1 (data not shown)21.
We conﬁrmed that induction of Notch signaling in primary
chondrocytes, irrespective of donor sex, inhibits progression to a
mature chondrocyte phenotype while inducing expression of
Col10a1 and Mmp1320,21. In previous work we reported that
chondrocyte-enriched cell cultures present minimal expression of
osteoblast gene markers, suggesting the presence of osteoblastic
cells21. Under selected conditions, osteoblasts express Mmp13,osaNotch chondrocyte-enriched cells were infected with AdeCMVeCre (CRE, full circles)
3 days under conditions favoring chondrocyte maturation and serum removed for 6 h,
as extracted 24 h after exposure to antibodies, and changes in gene expression analyzed
Rpl38 copy number. Observations represent cultures from individual mice n ¼ 3e4.
s between CRE and GFP in the presence of Anti-Il6.
Fig. 4. Il6 neutralization does not affect Sox9 and Col2a1 suppression and Col10a1 and Il6 induction by NICD. Primary RosaNotch chondrocyte-enriched cells were infected with Ade
CMVeCre (CRE, full circles) to induce NICD or with control AdeCMVeGFP (GFP, empty circles). Cells were cultured for 3 days under conditions favoring chondrocyte maturation and
serum removed for 6 h, before exposure to murine Il6 antibody (Anti-Il6) or control normal murine IgG. Total RNA was extracted 24 h after exposure to antibodies, and changes in
gene expression analyzed by qRT-PCR. Data are expressed as ratio of Sox9, Col2a1, Col10a1 and Il6 copy number over Rpl38 copy number. Observations represent cultures from
individual mice n ¼ 3e4. * indicates differences between CRE and GFP in the presence of IgG. ** indicates differences between CRE and GFP in the presence of Anti-Il6.
Fig. 5. Il6 neutralization opposes the effects of NICD on Acan and Mmp13 expression. Primary RosaNotch chondrocyte-enriched cells were infected with AdeCMVeCre (CRE, full
circles) to induce NICD or with control AdeCMVeGFP (GFP, empty circles). Cells were cultured for 3 days under conditions favoring chondrocyte maturation and serum removed for
6 h, before exposure to murine Il6 antibody (Anti-Il6) or control normal murine IgG. Total RNA was extracted 24 h after exposure to antibodies, and changes in gene expression
analyzed by qRT-PCR. Data are expressed as ratio of Prg4, Acan, Adamts4 and Mmp13 copy number over Rpl38 copy number. Observations represent cultures from individual mice
n ¼ 3e5. * indicates differences between CRE and GFP in the presence of IgG. ** indicates differences between CRE and GFP in the presence of Anti-Il6. þ indicates a difference
between IgG and Anti-Il6 in the context of CRE infection.
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exhibited by chondrocyte-enriched cell cultures overexpressing
NICD is due to the presence of contaminating osteoblasts46. How-
ever, Notch activation did not increase Mmp13 expression in pri-
mary osteoblast cultures (data not shown), indicating that the
effect is selective to cells of the chondrocyte lineage. NICD over-
expression led to the induction of Il6 and suppression of Acan
mRNA levels, but did not affect Prg4 or Adamts4 expression. These
ﬁndings indicate that Notch activation in murine chondrocytes
affects selected gene markers of chondrocyte function and cartilage
matrix degradation. It is important to mention that the model
culture used contains both articular and growth plate chon-
drocytes, limiting our ability to discern the cell population that is
responding to the Notch signal.
Notch transactivated the Il6 promoter and induced the release of
Il6 without affecting the stability of the Il6 mRNA, demonstrating
that Notch induces Il6 expression by transcriptional mechanisms.
Activity of the Il6 promoter and expression of Il6 were observed in
control cultures, and this is consistent with work from other lab-
oratories reporting expression of Il6 by chondrocytes under basal
conditions47. However, concentration of Il6 in the supernatant of
control cells was minimal and the neutralizing Il6 antibody had no
impact on chondrocyte gene markers expression in the absence of
Notch, suggesting that basal levels of Il6 are dispensable for
chondrocyte function. Induction of Il6 by Notch is in agreement
with previous studies carried out in bone marrow stromal cells,
macrophages and breast cancer cells, and conﬁrms that Il6 is a
direct target gene of Notch signaling26,48,49.
Activation of the Notch signaling pathway was not altered by Il6
neutralization, excluding the possibility that the effects of Il6 in-
hibition in the context of Notch induction are secondary to sup-
pression of Notch signaling. Although Il6 inhibited Sox9 and Col2a1
expression, Il6 neutralization did not prevent suppression of both
genes by Notch in RosaNotch chondrocyte-enriched cells, and this is
in agreement with previous studies demonstrating that HEY1 and
HES1 mediate the inhibitory effects of NICD on COL2A1 expression
in human chondrocytes27e29,45. The effects of Il6 on Col10a1
expression were not reported, and induction of Col10a1 by Notch
was not affected by Il6 neutralization, raising the possibility that
Col10a1, similarly to Hey genes and Hes1, is a direct target of Notch
signaling. In agreement with the effects of Il6 on Mmp13 in chon-
drocytes, Il6 neutralization precluded Mmp13 induction by Notch,
indicating that Il6 mediates this effect of Notch. Conversely, Il6
neutralization partially opposed suppression of Acan transcripts by
Notch in chondrocytes27e29. HEY1 overexpression inhibits ACAN
expression in human bone marrow-derived chondrocytes, sug-
gesting that suppression of Acan mRNA levels by Notch in murine
cells is mediated by induction of both Hey1 and Il645.
In conclusion, Il6 mediates induction of Mmp13 expression by
Notch and contributes to the inhibitory effect of Notch on Acan
mRNA levels in cells of the chondrocyte lineage.
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